GlassScriptPhysician profile
Miguel E Gonzalez
NPI 1750333480
$1,504.45
in general payments reported to CMS, 2019-2025
19 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $197 · 2021: $13.70 · 2022: $13.89 · 2023: $422 · 2024: $215 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $388.43 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $193.68 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $175.73 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $173.85 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Hydrocision, INC. | $105.87 | 2025 | Tenjet |
| Shield Therapeutics INC | $85.59 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $64.68 | 2024 | Uptravi |
| Sanofi-Aventis U.S. LLC | $55.95 | 2019-2020 | |
| Lilly USA, LLC | $46.13 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.78 | 2019-2020 | |
| Amgen INC. | $31.95 | 2022-2024 | Otezla, Repatha |
| Abbott Laboratories | $21.86 | 2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $21.70 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.26 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $18.24 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.19 | 2019 | |
| Erbe USA INC | $15.00 | 2024 | |
| Amarin Pharma, INC. | $14.23 | 2020 | |
| Osiris Therapeutics INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.